Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.770
+0.010 (0.27%)
At close: Apr 28, 2026, 4:00 PM EDT
3.740
-0.030 (-0.80%)
Pre-market: Apr 29, 2026, 7:01 AM EDT

Voyager Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-119.72-65132.33-46.41-71.2
Upgrade
Depreciation & Amortization
4.064.734.446.195.17
Upgrade
Loss (Gain) From Sale of Assets
0.140.510.180.38-
Upgrade
Asset Writedown & Restructuring Costs
-2.78---
Upgrade
Loss (Gain) From Sale of Investments
-2.97-7.97-3.63-0.020.35
Upgrade
Stock-Based Compensation
14.7914.7911.159.3411.32
Upgrade
Other Operating Activities
4.874.61.98-2.47-2.46
Upgrade
Change in Accounts Receivable
0.2781.31-83.230.487.28
Upgrade
Change in Accounts Payable
1.022.39-0.961.99-0.06
Upgrade
Change in Unearned Revenue
-28.81-44.849.4123.73-1.72
Upgrade
Change in Other Net Operating Assets
-6.11-8.66.25-5.73-2.21
Upgrade
Operating Cash Flow
-132.47-15.3177.92-12.51-53.53
Upgrade
Capital Expenditures
-2.6-3.52-3.26-2.49-1.61
Upgrade
Investment in Securities
128.04-91.34-138.39-4.8567.52
Upgrade
Investing Cash Flow
125.45-94.86-141.64-7.3465.91
Upgrade
Issuance of Common Stock
0.82114.0233.651.110.61
Upgrade
Financing Cash Flow
0.82114.0233.651.110.61
Upgrade
Net Cash Flow
-6.213.85-30.08-18.7412.99
Upgrade
Free Cash Flow
-135.06-18.8374.66-15-55.13
Upgrade
Free Cash Flow Margin
-334.53%-23.54%29.86%-36.67%-147.36%
Upgrade
Free Cash Flow Per Share
-2.30-0.331.68-0.39-1.46
Upgrade
Levered Free Cash Flow
-83.9425.61-3.017.253.94
Upgrade
Unlevered Free Cash Flow
-83.9425.61-3.017.254.18
Upgrade
Change in Working Capital
-33.6330.26-68.5320.473.29
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.